Denali Therapeutics, Inc. (DNLI)
19.66
-0.04
(-0.18%)
USD |
NASDAQ |
Dec 09, 16:00
17.70
-1.96
(-9.95%)
After-Hours: 20:00
Denali Therapeutics Total Liabilities (Quarterly): 129.42M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Masimo Corp. | 1.008B |
| Novavax, Inc. | 1.337B |
| iRhythm Technologies, Inc. | 873.32M |
| AIM ImmunoTech, Inc. | 11.57M |
| Protalix Biotherapeutics, Inc. | 29.36M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.056B |
| Shareholders Equity (Quarterly) | 926.20M |
| Debt to Equity Ratio | 0.0479 |
| Current Ratio | 9.791 |
| Net Debt Paydown Yield | 0.04% |